Pura Vida Investments, LLC 13D and 13G filings for OncoCyte Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 1:26 pm Sale |
2024-11-14 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 616,587 4.570% |
-91,585 (-12.93%) |
Filing |
| 2024-02-14 5:03 pm Sale |
2023-12-31 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 708,172 8.450% |
-123,919 (-14.89%) |
Filing |
| 2023-04-14 4:31 pm Sale |
2023-04-14 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 832,091 9.990% |
-70,723 (-7.83%) |
Filing |
| 2023-02-14 1:11 pm Unchanged |
2022-12-31 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 902,814 15.220% |
0 (Unchanged) |
Filing |
| 2023-02-14 11:33 am Purchase |
2022-12-31 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 902,814 15.220% |
291,616 (+47.71%) |
Filing |
| 2021-01-28 3:44 pm Purchase |
2021-01-20 | 13G | OncoCyte Corporation OCX |
Pura Vida Investments, LLC | 611,198 15.540% |
326,369 (+114.58%) |
Filing |